[1]
Zhang, J., Liu, W.-L., Zhang, L., Ge, R., He, F., Gao, T.-Y., Tian, Q., Mu, X., Chen, L.-H., Chen, W. and Li, X. 2018. MiR-637 suppresses melanoma progression through directly targeting P-REX2a and inhibiting PTEN/AKT signaling pathway. Cellular and Molecular Biology. 64, 11 (Aug. 2018), 50–57. DOI:https://doi.org/10.14715/cmb/2018.64.11.10.